Human PRKACa ELISA Kit Drug Target Proteins in LIGHT-induced tumor cell death

in LIGHT-induced tumor cell death and chemokine production

or High Mobility Group Box 1 protein

and HRP enzyme conjugate are sequentially added to microwells pre-coated with a Procollagen I (PCI) capture antibody

Patients with metastatic colorectal cancer that expresses EGFR may be treated with cetuximab in combination with chemotherapy or cetuximab may be given as a single therapy to patients who have failed to respond to irinotecan- and oxaliplatin-based regimens

various tumor cells constitutively express G-CSF

Human PRKACa ELISA Kit Drug Target Proteins in LIGHT-induced tumor cell deathProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and